Ecology- and Bioassay-Guided Drug Discovery for Treatments of Tropical Parasitic Disease: 5α,8α-Epidioxycholest-6-en-3β-ol Isolated from the Mollusk Dolabrifera dolabrifera Shows Significant Activity against Leishmania donovani
Free accessResearch articleFirst published online November, 2013
Ecology- and Bioassay-Guided Drug Discovery for Treatments of Tropical Parasitic Disease: 5α,8α-Epidioxycholest-6-en-3β-ol Isolated from the Mollusk Dolabrifera dolabrifera Shows Significant Activity against Leishmania donovani
An ecology- and bioassay-guided search employed to discover compounds with activity against tropical parasitic diseases and cancer from the opisthobranch mollusk, Dolabrifera dolabrifera, led to the discovery of antileishmanial properties in the known compound, 5α,8α-epidioxycholest-6-en-3β-ol (1). Compound 1 was identified through nuclear magnetic resonance spectroscopy (1H, 13C) and mass spectrometry. The compound was concentrated in the digestive gland of D. dolabrifera, but was not detected in other body parts, fecal matter or mucus. Compound 1 showed an IC50 of 4.9 μM towards the amastigote form of Leishmania donovani compared with an IC50 of 281 μM towards the control Vero cell line, a 57.3-fold difference, and demonstrated no measurable activity against Plasmodium falciparum, Trypanosoma cruzi, and the breast cancer cell line, MCF-7.
PolonioT., EffertT. (2008) Leishmaniasis: Drug resistance and natural products (Review). International Journal of Molecular Medicine, 22, 277–286.
2.
MurrayH.W. (2001) Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrobial Agents and Chemotherapy, 45, 2185–2197.
3.
Siqueira-NetoJ.L., SongO.R., OhH., SohnJ.H., YangG., NamJ., JangJ., CechettoJ., LeeC.B., MoonS., GenovesioA., ChatelainE., ChristopheT.T., Freitas-JuniorL.H. (2010) Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds. PLoS Neglected Tropical Diseases, 4, e675.
4.
O'NeillP.M., BartonV.E., WardS.A. (2010) The molecular mechanism of action of artemisinin–the debate continues. Molecules, 15, 1705–1721.
5.
RochaL.G., AlmeidaJ.R., MacêdoR.O., Barbosa-FilhoJ.M. (2005) A review of natural products with antileishmanial activity. Phytomedicine, 12, 514–535.
6.
TemponeA.G., Martins de OliveiraC., BerlinckR.G. (2011) Current approaches to discover marine antileishmanial natural products. Planta Medica, 77, 572–585.
7.
HelsonJ.E., CapsonT.L., JohnsT., AielloA., WindsorD.M. (2009) Ecological and evolutionary bioprospecting: using aposematic insects as guides to rainforest plants active against disease. Frontiers in Ecology and the Environment, 7, 130–134.
8.
SimmonsT.L., AndrianasoloE., McPhailK., FlattP., GerwickW.H. (2005) Marine natural products as anticancer drugs. Molecular Cancer Therapeutics, 4, 333–342.
9.
BehrensD.W., HermosilloA. (2005) In Eastern pacific nudibranchs: A guide to the opisthobranchs from Alaska to Central America.Sea Challengers.Monterey, CA.
10.
WatsonM. (1973) Midgut gland toxins of Hawaiian sea hares-1. Isolation and preliminary toxicological observations. Toxicon, 11, 259–267.
11.
BenkendorffK., DavisA.R., BremnerJ.B. (2001) Chemical defense in the egg masses of benthic invertebrates: An assessment of antibacterial activity in 39 mollusks and 4 polychaetes. Journal of Invertebrate Pathology, 78, 109–118.
12.
CiavattaM.L., GavagninM., PulitiR., CiminoG. (1996) Dolabriferol: A new polypropionate from the skin of the anaspidean mollusc Dolabrifera dolabrifera. Tetrahedron, 52, 12831–12838.
13.
GunatilakaA.A.L., GopichandY., SchmitzF.J., DjerassiC. (1981) Minor and trace sterols in marine invertebrates. 26. Isolation and structure elucidation of nine new 5α,8α-epidioxy sterols from four marine organisms. Journal of Organic Chemistry, 46, 3860–3866.
14.
AbourricheA., CharroufM., ChaibN., BennamaraA., BontempsN., FranciscoC. (2000) Isolation and bioactivities of epidioxysterol from the tunicate Cynthia savignyi. Farmaco, 55, 492–494.
15.
AkninM., ViracaoundinI., FaureR., GaydouE.M. (1998) 5α-8α-Epidioxycholest-6-en-3-β-ol from three cone snails of the Indian Ocean. Journal of the American Oil Chemists’ Society, 75, 1679–1681.
16.
BensemhounJ., BombardaI., AkninM., FaureR., GaydouE.M. (2008) 5α,8α-Epidioxysterols from the tunicate Didemnum salary. Biochemical Systematics and Ecology, 36, 942–944.
17.
GauvinA., SmadjaJ., AkninM., FaureR., GaydouE-M. (2000) Isolation of bioactive 5α,8α-epidioxy sterols from the marine sponge Luffariella cf. variabilis. Canadian Journal of Chemistry, 78, 986–992.
18.
IoannouE., Abdel-RazikA.F., ZervouM., ChristofidisD., AlexiX., VagiasC., AlexisM.N., RoussisV. (2009) 5α,8α-Epidioxysterols from the gorgonian Eunicella cavolini and the ascidian Trididemnum inarmatum: Isolation and evaluation of their antiproliferative activity. Steroids, 74, 73–80.
19.
IwashimaM., TeradaI., IguchiK., YamoriT. (2002) New biologically active marine sesquiterpenoid and steroid from the Okinawan sponge of the genus Axinyssa. Chemical and Pharmaceutical Bulletin, 50, 1286–1289.
20.
JiménezC., QuiñoáE., CastedoL., RigueraR. (1986) Epidioxy sterols from the tunicates Dendrodoa grossularia and Ascidiella aspersa and the gastropoda Aplysia depilans and Aplysia punctata. Journal of Natural Products, 49, 905–909.
21.
JiménezC., QuiñoáE., RigueraR., VilaltaR., QuintelaJ.M. (1989) The dietary origin of epidioxy steroids in Actinia equina. A carbon-14 incorporation experiment. Journal of Natural Products, 52, 619–622.
22.
MansoorT.A., LeeY.M., HongJ., LeeC.O., ImK.S., JungJ.H. (2006) 5,6:8,9-Diepoxy and other cytotoxic sterols from the marine sponge Homaxinella sp. Journal of Natural Products, 69, 131–134.
23.
MárquezD.M., MartínezA. (2007) Antileishmanial epidioxysterols from the Colombian marine sponge Ircinia campana are oxidation products from naturally occurring Δ5,7 sterols. Vitae, Revista de la Facultad de Química Farmacéutica, 14, 61–66.
24.
PanM.H., HuangY.T., ChangC.I., HoC.T., PanB.S. (2007) Apoptotic-inducing epidioxysterols identified in hard clam (Meretrix lusoria). Food Chemistry, 102, 788–795.
25.
MinhC.V., KiemP.V., HuongL.M., KimY.H. (2004) Cytotoxic constituents of Diadema setosum. Archives of Pharmaceutical Research, 27, 734–737.
26.
MiyamotoT., HondaM., SugiyamaS., HiguchiR., KomoriT. (2006) Studies on the constituents of marine opisthobranchia. III. Isolation and structure of two 5,8α-epidioxysterols and a cholesteryl ester mixture from the albumen gland of Aplysia juliana. Liebigs Annalen der Chemie, 1988, 589–592.
27.
SeraY., AdachiK., ShizuriY. (1999) A new epidioxy sterol as an antifouling substance from a Palauan marine sponge, Lendenfeldia chondrodes. Journal of Natural Products, 62, 152–154.
28.
SheuJ.H., ChangK.C., DuhC.Y. (2000) A cytotoxic 5α,8α-epidioxysterol from a soft coral Sinularia species. Journal of Natural Products, 63, 149–151.
BobzinS.C., FaulknerD.J. (1992) Chemistry and chemical ecology of the Bahamian sponge Aplysilla glacialis. Journal of Chemical Ecology, 18, 309–322.
31.
PenningsS.C., PaulV.J., DunbarD.C., HamannM.T., LumbangW.A., NovackB., JacobsR.S. (1999) Unpalatable compounds in the marine gastropod Dolabella auricularia: Distribution and effect of diet. Journal of Chemical Ecology, 25, 735–755.
32.
TakagiK.K., OnoN.N., WrightW.G. (2010) Interspecific variation in palatability suggests cospecialization of antipredator defenses in sea hares. Marine Ecology Progress Series, 416, 137–144.
33.
MeshnickS.R., TsangT.W., LinF.B., PanH.Z., ChangC.N., KuypersF., ChiuD., LubinB. (1989) Activated oxygen mediates the antimalarial activity of qinghaosu. Progress in Clinical and Biological Research, 313, 95–104.
34.
LiJ., ZhouB. (2010) Biological actions of artemisinin: Insights from medicinal chemistry studies. Molecules, 15, 1378–1397.
35.
CorbettY., HerreraL., GonzálezJ., CubillaL., CapsonT.L., ColeyP.D., KursarT.A., RomeroL.I., Ortega-BarríaE. (2004) A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity. American Journal of Tropical Medicine and Hygiene, 70, 119–124.
36.
BucknerF.S., VerlindeC.L., La FlammeA.C., Van VoorhisW.C. (1996) Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrobial Agents and Chemotherapy, 40, 2592–2597.
37.
CalderónA.I., RomeroL.I., Ortega-BarríaE., BrunR., CorreaM.D., GuptaM.P. (2006) Evaluation of larvicidal and in vitro antiparasitic activities of plants in a biodiversity plot in the Altos de Campana National Park, Panama. Pharmaceutical Biology, 44, 487–498.
38.
MonksA., ScudieroD., SkehanP., ShoemakerR., PaullK., VisticaD., HoseC., LangleyJ., CroniseP., Vaigro-WolffA., Gray-GoodrichM., CampbellH., MayoJ., BoydM. (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. Journal of the National Cancer Institute, 83, 757–766.
